Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
pharmacokinetic-based theory on altered drug activity
|
age-related decline of drug disposition & metabolism
|
|
pharmacodynamic-based theory on altered drug activity
|
altered quantity and/or quality of drug receptor sites
|
|
general geriatric absorption changes (4)
|
1. ↑ pH ( ↓ gastric acid secretion)
2. ↓ gastric (splanchnic) blood flow 3. ↓ gastric emptying rate 4. ↓ absorptive surface area (villa atrophy & ↑ mucosal connective tissue) |
|
↑ pH affect on drugs (2)
|
1. dissolution rate of drugs
2. drug stability |
|
↑ pH affects which drugs and how? (5)
|
1. penicillin (stabilized)
2. erythromycin (stabilized) 3. clorazepate (needs acid-cleaving, thus ↓ absorption) 4. dapsone (↓ absorption) 5. itraconazole (↓ absorption) |
|
↓ gastric (splanchnic) blood flow affect on which drugs and how?
|
may ↑ availability of drugs w/ significant first-pass metabolism
|
|
↓ absorptive surface area implications (2)
|
1. ↓ active transport mechanisms (calcium, iron, thiamine, folic acid, sugars, amino acids)
2. no change in passive absorption |
|
extent of absorption
|
unchanged in geriatrics
|
|
Cmax in geriatrics & implication
|
possible ↑ due to ↓ elimination
clinically manifest as delayed onset of action |
|
geriatric changes in distribution (3)
|
1. alterations in body composition
2. alterations in serum proteins 3. perfusion |
|
alterations in body composition (2)
|
1. ↓ TBW
2. ↓ lean muscle mass & ↑ body fat |
|
↓ TBW implications & drugs affected (7)
|
↓ TBW, ↑ concentration of water soluble drugs
1. aminoglycosides 2. ethanol 3. lithium 4. procainamide 5. quinidine 6. theophylline 7. warfarin |
|
↓ lean muscle mass & ↑ body fat implications & drugs affected (5)
|
↓ lean muscle mass & ↑ body fat , ↑ distribution of lipid soluble drugs thus delayed effect, drug accumulation, ↑ HL & prolonged action
1. TCA 2. benzodiazepines 3. barbiturates 4. steroids 5. phenothiazines |
|
alterations in serum proteins (2)
|
1. ↓ albumin
2. ↑ alpha-1 acid glycoprotein |
|
↓ albumin implications & drugs affected
|
↑ unbound fraction for highly bound acidic drugs
phenytoin |
|
↑ alpha-1 acid glycoprotein
|
acute phase reactant that may be ↑ in elderly w/ multiple disease states, thus ↑ binding of highly basic drugs & ↓ in unbound drug fraction
lidocaine |
|
perfusion & implications (2)
|
1. ↓ CO
2. ↓ Vd |
|
metabolic changes in the elderly (3)
|
1. changes in liver composition
2. biotransformation 3. induction/inhibition of drug metabolism |
|
changes in liver composition (3)
|
1. ↓ hepatic blood flow
2. ↓ hepatic mass 3. ↓ functional hepatocytes |
|
biotransformation (2)
|
1. Phase I (p450, mixed function oxidase reactions) ↓ w/ age
2. Phase II (conjugation, glucuronidation, etc.) not changed w/ age |
|
Phase I drugs affected
|
benzodiazepines
|
|
changes in kidneys (3)
|
1. ↓ renal blood flow
2. ↓ renal tubular function 3. ↓ GFR |
|
renally dose-adjusted antimicrobials (6)
|
1. acyclovir
2. aminoglycosides 3. cephalosporins (most) 4. imipenem 5. penicillins (most) 6. vancomycin |
|
renally dose-adjusted cardiovasculars (3)
|
1. atenolol
2. captopril 3. digoxin |
|
renally dose-adjusted H2 blockers (3)
|
1. cimetidine
2. ranitidine 3. famotidine |
|
misc. renal dose-adjusted drugs (4)
|
1. lithium
2. metformin 3. meperidine 4. procainamide |
|
drugs w/ ↑ receptor sensitivity (7)
|
1. benzodiazepines
2. warfarin 3. hypotensives 4. central effects of anticholinergics 5. NSAIDs 6. phenothiazines 7. opiates |
|
drugs w/ ↓ receptor sensitivity (2)
|
1. possibly CCBs
2. β-adrenergic blockers & agonists |
|
implications of ↓ beta receptor sensitivity
|
Beta-adrenergic mediated signs of hypoglycemia may be attenuated in the elderly and delay its detection
|
|
implications of ↓ adrenergic receptor sensitivity
|
Diminished myocardial response to adrenergic stimuli may contribute to orthostatic hypotension
|
|
↑ central effects of anticholinergics implications
|
confusion, lethargy, drowsiness
|
|
diuresis
|
↑ sensitivity to diuresis
|
|
electrolyte changes
|
↑ effects of hyperkalemia & hyponatremia
|
|
dopamine-receptor blocking agents (2) & implications
|
ex. metoclopramide & antipsychotics may induce Parkinson’s like syndromes
|
|
NSAIDS (2)
|
1. ↑ susceptibility to the GI AEs of NSAIDS
2. avoid indomethacin because of ↑ risk of CNS toxicity (confusion, lethargy) |